Maple Grove, MN, United States of America

Srikara V Peelukhana

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Srikara V Peelukhana

Introduction

Srikara V Peelukhana is an accomplished inventor based in Maple Grove, MN (US). He has made significant contributions to the field of medical technology, particularly in the modeling of lung conditions. With a total of five patents to his name, Peelukhana's work demonstrates a commitment to advancing healthcare solutions.

Latest Patents

One of his latest patents involves a method for modeling a collapsed lung using computed tomography (CT) data. This innovative approach includes acquiring CT data of a patient's lungs and utilizing a software application to differentiate the tissue within the lungs. The process generates a 3-D model based on the acquired data, applies material properties to the differentiated tissues, and calculates the displacement of the lungs in a collapsed state. Ultimately, this method displays a collapsed lung model based on the calculated displacements, providing valuable insights for medical professionals.

Career Highlights

Throughout his career, Srikara has worked with notable companies such as Covidien LP and Medtronic, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Srikara has collaborated with professionals like Joe Don Sartor and Arlen K Ward, enhancing his projects through teamwork and shared expertise.

Conclusion

Srikara V Peelukhana's contributions to medical technology through his patents and collaborations highlight his dedication to improving healthcare solutions. His innovative methods for modeling lung conditions are paving the way for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…